Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
Liminatus Pharma shares are trading lower. The company announced it amended its proposed $320 merger deal with InnocsAI.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.